What Does Versant Ventures Do?

Total employees67
HeadquartersSan Francisco
Founded1999

Versant Ventures is a premier healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of life-changing companies. The firm invests across the healthcare sector, with a primary focus on biopharmaceuticals, medical devices, and healthcare technology. Versant has a global presence and actively partners with entrepreneurs from discovery and company formation through clinical development and commercialization, aiming to translate groundbreaking science into impactful therapies and solutions for patients.

Where Is Versant Ventures's Headquarters?

Versant Ventures officeVersant Ventures officeVersant Ventures officeVersant Ventures office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as a central hub for investment activities, portfolio company management, deal sourcing, and networking within the prominent U.S. West Coast biotech ecosystem.

Notable Features:

Located in the One Sansome Street skyscraper (Citigroup Center), a prominent Class A office building in San Francisco's Financial District, offering modern office facilities and panoramic city views.

Work Culture:

A dynamic, collaborative, and science-driven environment focused on identifying and nurturing groundbreaking healthcare innovations. The culture emphasizes deep scientific and clinical diligence, hands-on company building, and a long-term commitment to portfolio companies.

HQ Significance:

The San Francisco location provides direct access to one of the world's leading biotech clusters, including world-class research institutions, a dense network of startups, experienced talent, and co-investors.

Values Reflected in HQ: The choice of a prime San Francisco location reflects Versant's commitment to being at the forefront of innovation, fostering collaboration within the biotech ecosystem, and maintaining a high standard of professionalism and strategic presence.

Location:

Versant Ventures operates with a significant global footprint, with established offices and teams in key innovation hubs across North America (USA and Canada) and Europe (Switzerland and France). This international presence enables the firm to source a diverse range of investment opportunities, build globally competitive companies by accessing talent and resources worldwide, and leverage its Discovery Engines for de novo company creation. Functions supported globally include deal sourcing, scientific and clinical due diligence, investment execution, hands-on portfolio company building and support, and fostering international collaborations within the life sciences industry.

Street Address:

One Sansome Street, Suite 3650

City:

San Francisco

State/Province:

CA

Country:

USA

Where Else Does Versant Ventures Operate Around the World?

Basel, Switzerland

Address: Aeschenvorstadt 56, 4051 Basel, Switzerland

Focuses on identifying and nurturing European life sciences innovation, company creation (particularly via its discovery engines), and providing access to the European market and talent.

New York, NY, USA

Address: 7 World Trade Center, 250 Greenwich Street, 46th Floor, New York, NY 10007, USA

Supports deal origination, investment execution, and collaboration with East Coast-based entrepreneurs, institutions, and the financial community.

Toronto, ON, Canada

Address: MaRS Centre, West Tower, 661 University Avenue, Suite 465, Toronto, ON M5G 1M1, Canada

To foster and fund Canadian biotech innovation, particularly in areas of novel therapeutics and platform technologies, often in partnership with local academic institutions.

San Diego, CA, USA

Address: 9920 Pacific Heights Blvd, Suite 150, San Diego, CA 92121, USA

Taps into San Diego's rich pool of scientific talent and biotech startups, particularly in genomics, oncology, immunology, and cell therapy.

Vancouver, BC, Canada

Address: #400 – 6190 Agronomy Road, Vancouver, BC V6T 1Z3, Canada

Drives early-stage drug discovery and company creation through a dedicated research team embedded within a leading Canadian university.

Paris, France

Address: Undisclosed specific street address, generally located in Paris.

To access and invest in French innovation, particularly in areas like gene therapy, immuno-oncology, and rare diseases, and to support the growth of French biotech companies on a global scale.

Buying Intent Signals for Versant Ventures

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Versant Ventures? Meet the Executive Team

As of April 2025, Versant Ventures' leadership includes:

Brad Bolzon, PhD - Chairman and Managing Director
Jerel Davis, PhD - Managing Director
Tom Woiwode, PhD - Managing Director
Clare Ozawa, PhD - Managing Director
Alex Mayweg, PhD - Managing Director
Guido Magni, MD, PhD - Managing Director (Venture Partner)
Carlo Rizzuto, PhD - Managing Director (Venture Partner)

Who's Investing in Versant Ventures?

Versant Ventures has been backed by several prominent investors over the years, including:

Versant Ventures is a venture capital firm that raises capital from Limited Partners (LPs) to invest in portfolio companies. LPs typically include institutional investors such as pension funds, university endowments, foundations, sovereign wealth funds, and family offices. The specific identities of LPs for each fund are generally kept confidential.

What Leadership Changes Has Versant Ventures Seen Recently?

Hire3
Exits0

Over the past 12 months (mid-2023 to mid-2024), Versant Ventures has actively strengthened its team through strategic promotions and new hires, particularly at the Operating Partner and Venture Partner levels. These appointments enhance the firm's capabilities in company building and investment expertise. No high-profile executive departures have been publicly announced during this period.

New Appointments:

Dr. Laura Brege, Dr. Laura Brege promoted to Operating Partner, enhancing support for portfolio companies.
Dr. Wouter Verhoef, Dr. Wouter Verhoef appointed as Venture Partner to bolster biopharmaceutical development expertise.
Dr. Graham Jang, Dr. Graham Jang appointed as Venture Partner, bringing valuable scientific and industry experience.

What Technology (Tech Stack) Is Used byVersant Ventures?

Discover the tools Versant Ventures uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Versant Ventures Email Formats and Examples

Email formats for Versant Ventures most commonly use the [first_initial][last]@[domain] pattern. While other formats might exist, this is a widely observed structure for professionals at the firm.

[first_initial][last]@versantventures.com

Format

jdoe@versantventures.com

Example

75%

Success rate

What's the Latest News About Versant Ventures?

BioSpace • March 13, 2024

Versant Ventures Promotes Dr. Laura Brege to Operating Partner

Versant Ventures announced the promotion of Laura Brege, Ph.D., to operating partner. Dr. Brege will leverage her extensive biopharma leadership experience to provide strategic and operational support to Versant’s portfolio companies....more

PR Newswire / Versant Ventures • February 20, 2024

Versant Portfolio Company Abivax Announces Successful $203 Million U.S. IPO on Nasdaq

Abivax (Euronext Paris and Nasdaq: ABVX), a clinical-stage biotech company developing novel therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases, and a Versant Ventures portfolio company, announced the successful closing of its U.S. Initial Public Offering on Nasdaq, raising approximately $203 million in gross proceeds....more

GlobeNewswire / Versant Ventures • January 8, 2024

Versant-Incubated Altumira Bio and Ares Immunotherapies Merge to Create Abdera Therapeutics, Launching with $142M in Financing

Two Versant Ventures-incubated companies, Altumira Bio and Ares Immunotherapies, announced their merger to form Abdera Therapeutics, a new precision oncology company focused on developing next-generation targeted radiopharmaceuticals. Abdera launched with a combined $142 million Series A and B financing led by Versant Ventures....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Versant Ventures, are just a search away.